Globus Medical (GMED) Receivables - Net (2011 - 2026)

Globus Medical (GMED) has 16 years of Receivables - Net data on file, last reported at $686.4 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 28.28% year-over-year to $686.4 million; the trailing twelve-month figure through Mar 2026 stood at $686.4 million (up 28.28% YoY), and the FY2025 full-year result was $678.9 million, up 21.74% from the prior year.
• Receivables - Net for Q1 2026 stood at $686.4 million, up from $678.9 million in the prior quarter.
• Across five years, Receivables - Net topped out at $686.4 million in Q1 2026 and bottomed at $166.2 million in Q1 2022.
• The 5-year median for Receivables - Net is $534.3 million (2024), against an average of $450.7 million.
• The widest annual swing landed in 2024, when Receivables - Net surged 154.71%; it then retreated 0.04% in 2025.
• A 5-year view of Receivables - Net shows it stood at $213.2 million in 2022, then soared by 135.99% to $503.2 million in 2023, then gained by 10.82% to $557.7 million in 2024, then grew by 21.74% to $678.9 million in 2025, then increased by 1.1% to $686.4 million in 2026.
• The last three Receivables - Net figures came in at $686.4 million (Q1 2026), $678.9 million (Q4 2025), and $619.1 million (Q3 2025), per Business Quant data.

Peer Comparison